{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:27:43Z","timestamp":1773077263443,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T00:00:00Z","timestamp":1286409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/hr.2010.175","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T02:02:44Z","timestamp":1286416964000},"page":"1264-1271","source":"Crossref","is-referenced-by-count":7,"title":["The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial"],"prefix":"10.1038","volume":"33","author":[{"name":"for the I-HAT investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Toi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,7]]},"reference":[{"key":"BFhr2010175_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/sj.jhh.1001602","volume":"17","author":"Nippon Data 80 Research Group","year":"2003","unstructured":"Nippon Data 80 Research Group. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese -Nippon data 80-. J Hum Hypertens 2003; 17: 851\u2013857.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010175_CR2","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","volume":"31","author":"Y Tanizaki","year":"2000","unstructured":"Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M . Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke 2000; 31: 2616\u20132622.","journal-title":"Stroke"},{"key":"BFhr2010175_CR3","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"Prospective Studies Collaboration","year":"2002","unstructured":"Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults. Lancet 2002; 360: 1903\u20131913.","journal-title":"Lancet"},{"key":"BFhr2010175_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","volume":"21","author":"CM Lawes","year":"2003","unstructured":"Lawes CM, Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21: 707\u2013716.","journal-title":"J Hypertens"},{"key":"BFhr2010175_CR5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"K Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodr\u00edguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F . Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363\u20132369.","journal-title":"JAMA"},{"key":"BFhr2010175_CR6","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","volume":"31","author":"Y Tanizaki","year":"2000","unstructured":"Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M . Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama study. Stroke 2000; 31: 2616\u20132622.","journal-title":"Stroke"},{"key":"BFhr2010175_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","volume":"355","author":"JA Staessen","year":"2000","unstructured":"Staessen JA, Gasowski J, Wang JG, Thijs L, Hond ED, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu F, Kerlikowske K, Pocock S, Fagard RH . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865\u2013872.","journal-title":"Lancet"},{"key":"BFhr2010175_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","volume":"358","author":"JA Staessen","year":"2001","unstructured":"Staessen JA, Wang JG, Thijs L . Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305\u20131315.","journal-title":"Lancet"},{"key":"BFhr2010175_CR9","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"Blood Pressure Lowering Treatment Trialists Collaboration","year":"2003","unstructured":"Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362: 1527\u20131545.","journal-title":"Lancet"},{"key":"BFhr2010175_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jacc.2005.03.070","volume":"46","author":"T Ohkubo","year":"2005","unstructured":"Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y . Prognosis of \u2018Masked\u2019 hypertension and \u2018White-Coat\u2019 hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508\u2013515.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010175_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1001\/jama.291.11.1342","volume":"291","author":"G Bobrie","year":"2004","unstructured":"Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM . Cardiovascular prognosis of \u2018Masked Hypertension\u2019 detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342\u20131349.","journal-title":"JAMA"},{"key":"BFhr2010175_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00004872-199816070-00010","volume":"16","author":"T Ohkubo","year":"1998","unstructured":"Ohkubo T, Imai Y, Tsuji I, Nagai K, Katoh J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S . Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama Japan. J Hypertens 1998; 16: 971\u2013975.","journal-title":"J Hypertens"},{"key":"BFhr2010175_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000160923.04524.5B","volume":"111","author":"R Sega","year":"2005","unstructured":"Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G . Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the pressioni arteriose monitorate e loro associazioni (PAMELA) study. Circulation 2005; 111: 1777\u20131783.","journal-title":"Circulation"},{"key":"BFhr2010175_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/hr.2008.18","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, on behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 4\u2013107.","journal-title":"Hypertens Res"},{"key":"BFhr2010175_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1081\/CEH-120004230","volume":"24","author":"K Chonan","year":"2002","unstructured":"Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, Hozawa A, Matsubara M, Suzuki M, Fujiwara T, Araki T, Satoh H, Hisamichi S, Imai Y . Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens 2002; 24: 261\u2013275.","journal-title":"Clin Exp Hypertens"},{"key":"BFhr2010175_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145\u2013153.","journal-title":"N Engl J Med"},{"key":"BFhr2010175_CR17","first-page":"2217","volume":"292","author":"SE Nissen","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ, for the CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary heart disease and normal blood pressure. The CAMELOT Study: a randomized controlled trial. JAMA 2004; 292: 2217\u20132226.","journal-title":"The CAMELOT Study: a randomized controlled trial. JAMA"},{"key":"BFhr2010175_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.diabres.2008.11.011","volume":"83","author":"R Kawamori","year":"2009","unstructured":"Kawamori R, Fujita T, Matsuoka T, Umemura S, Saito Y . Relation between cardiovascular complications blood pressure\/blood glucose control in diabetic patients with hypertension receiving long-term candesartan cilexetil therapy: Challenge-DM study. Diabetes Res Clin Pract 2009; 83: 241\u2013248.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFhr2010175_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1291\/hypres.31.1595","volume":"31","author":"T Ogihara","year":"2008","unstructured":"Ogihara T, Nakao K, Fukui T, Fukiyama K, Fujimoto A, Ueshima K, Oba K, Shimamoto K, Matsuoka H, Saruta T, for the CASE-J trial group. The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high risk hypertension: A Subanalysis of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial. Hypertens Res 2008; 31: 1595\u20131601.","journal-title":"Hypertens Res"},{"key":"BFhr2010175_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/hr.2008.34","volume":"32","author":"T Ogihara","year":"2009","unstructured":"Ogihara T, Saruta T, Rakugi H, Fujimoto A, Ueshima K, Yasuno S, Oba K, Takeda K, Higaki J, Nakao K, on behalf of the CASE-J trial group. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial. Hypertens Res 2009; 32: 248\u2013254.","journal-title":"Hypertens Res"},{"key":"BFhr2010175_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/jhh.2009.76","volume":"24","author":"M Thoenes","year":"2010","unstructured":"Thoenes M, Neuberger H-R, Volpe M, Khan BV, Kirchl W, Bohm M . Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens 2010; 24: 336\u2013344.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010175_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1291\/hypres.29.143","volume":"29","author":"H Mori","year":"2006","unstructured":"Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S . Current status of antihypertensive prescription associated blood pressure control in Japan. Hypertens Res 2006; 29: 143\u2013151.","journal-title":"Hypertens Res"},{"key":"BFhr2010175_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1161\/01.STR.0000158925.12740.87","volume":"36","author":"C Li","year":"2005","unstructured":"Li C, Engstr\u00f6m G, Hedblad B, Berglund G, Janzon L . Blood pressure control and risk of stroke: A population-based prospective cohort study. Stroke 2005; 36: 725\u2013730.","journal-title":"Stroke"},{"key":"BFhr2010175_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11906-996-0005-z","volume":"4","author":"WJ Elliot","year":"2002","unstructured":"Elliot WJ . Is fixed combination therapy appropriate for initial hypertension treatment. Curr Hypertens Reports 2002; 4: 278\u2013285.","journal-title":"Curr Hypertens Reports"},{"key":"BFhr2010175_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/080370598437574","volume":"7","author":"O Anderson","year":"1998","unstructured":"Anderson O, Neldam T . The antihypertensive effect tolerability of candesartan cilexetiI a new generation angiotensin II antagonist in comparison with losartan. Blood Press 1998; 7: 53\u201359.","journal-title":"Blood Press"},{"key":"BFhr2010175_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1524-6175.2001.01136.x","volume":"3","author":"S Oparil","year":"2001","unstructured":"Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J . Comparative efficacy of olmesartan, losartan, valsartan, and Irbesartan in the control of essential hypertension. J Clin Hypertens 2001; 3: 283\u2013291.","journal-title":"J Clin Hypertens"},{"key":"BFhr2010175_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1177\/00912700022008685","volume":"40","author":"DG Smith","year":"2000","unstructured":"Smith DG, Matzek KM, Kempthorne-Rawson J . Dose response safety of telmisartan in patients with mild to moderate hypertension. J Clin Pharmacol 2000; 40: 1380\u20131390.","journal-title":"J Clin Pharmacol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:06:00Z","timestamp":1684415160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,7]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFhr2010175"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.175","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,7]]}}}